Assignee
Metys Pharmaceuticals AG
CH·1 granted patent·3 pending applications·0 citations·filing 2018–2020
Top patents by PatentIndex Score
4 records- 0156US10738054B2Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratioMetys Pharmaceuticals AG·Filed 2018·Granted Aug 11, 2020·0 cites·23 claims
- 0254US2020331919A1Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratioMetys Pharmaceuticals AG·Filed 2020·Application pending·0 cites
- 0343US2022047548A1SYNERGISTIC COMPOSITIONS COMPRISING (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE AND (S)-2-(2-e OXOPYRROLEDIN-1-YL)BUTANAMEDE IN A NON-RACEMIC RATIOMetys Pharmaceuticals AG·Filed 2019·Application pending·0 cites
- 0436US2022047587A1Synergistic compositions comprising r-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2h)-ones and s-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2h)-ones in a non-racemic ratioMetys Pharmaceuticals AG·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Metys Pharmaceuticals AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →